BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$78.3M |
| 2 |
PG&E
PCG
|
+$68.5M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$58.9M |
| 4 |
Deere & Co
DE
|
+$47.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.43B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$792M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$707M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 4.88% |
| 2 | Financials | 4.8% |
| 3 | Healthcare | 4.48% |
| 4 | Technology | 4.38% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
3826
DELISTED
ChemoCentryx, Inc.
CCXI
| $30.8K | ﹤0.01% |
5,178
+3,019
| +140% | +$20.7K |
|
|
PVBC
3827
DELISTED
Provident Bancorp
PVBC
| $30.7K | ﹤0.01% |
2,344
+1,511
| +181% | +$17.9K |
|
|
FOGO
3828
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $30.7K | ﹤0.01% |
2,645
+1,846
| +231% | +$21.3K |
|
3829
Viridian Therapeutics
VRDN
$2.61B
| $30.6K | ﹤0.01% |
195
+113
| +138% | +$14.4K |
|
|
DRRX
3830
DELISTED
DURECT Corp
DRRX
| $30.5K | ﹤0.01% |
3,309
+2,014
| +156% | +$23.9K |
|
|
EPE
3831
DELISTED
EP Energy Corporation
EPE
| $30.5K | ﹤0.01% |
12,917
+5,444
| +73% | +$13K |
|
|
VBIV
3832
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $30.4K | ﹤0.01% |
237
+166
| +234% | +$20.4K |
|
|
IVAC
3833
DELISTED
Intevac Inc
IVAC
| $30.3K | ﹤0.01% |
4,418
+2,521
| +133% | +$19.3K |
|
3834
TC Energy
TRP
$66B
| $30.3K | ﹤0.01% |
622
| – | – |
|
3835
Veracyte
VCYT
$3.72B
| $30.3K | ﹤0.01% |
4,633
+2,238
| +93% | +$16.6K |
|
|
DNBF
3836
DELISTED
DNB Financial Corp
DNBF
| $30K | ﹤0.01% |
889
+587
| +194% | +$19.7K |
|
3837
Clearfield
CLFD
$391M
| $29.9K | ﹤0.01% |
2,437
+1,459
| +149% | +$19.6K |
|
|
TPHS
3838
DELISTED
Trinity Place Holdings Inc.com
TPHS
| $29.7K | ﹤0.01% |
4,278
+2,073
| +94% | +$14.6K |
|
3839
Genco Shipping & Trading
GNK
$1.09B
| $29.7K | ﹤0.01% |
2,231
+1,481
| +197% | +$17.8K |
|
3840
Blue Bird Corp
BLBD
$2.07B
| $29.6K | ﹤0.01% |
1,488
+1,095
| +279% | +$21.7K |
|
|
CLSD
3841
DELISTED
Clearside Biomedical
CLSD
| $29.6K | ﹤0.01% |
282
+149
| +112% | +$16K |
|
3842
Pure Cycle
PCYO
$270M
| $29.5K | ﹤0.01% |
3,534
+1,865
| +112% | +$14K |
|
3843
Civeo
CVEO
$330M
| $29.4K | ﹤0.01% |
896
-125
| -12% | -$3.44K |
|
|
ARC
3844
DELISTED
ARC Document Solutions, Inc.
ARC
| $29.3K | ﹤0.01% |
11,499
+7,330
| +176% | +$24.1K |
|
|
TNAV
3845
DELISTED
Telenav Inc.
TNAV
| $29.1K | ﹤0.01% |
5,289
+2,121
| +67% | +$11.8K |
|
3846
ReposiTrak
TRAK
$153M
| $29.1K | ﹤0.01% |
3,042
+1,847
| +155% | +$20.3K |
|
3847
Stellantis
STLA
$21B
| $29K | ﹤0.01% |
+1,623
| New | +$28.5K |
|
3848
Fortress Biotech
FBIO
$91.4M
| $28.7K | ﹤0.01% |
480
+245
| +104% | +$14.4K |
|
3849
KALA BIO
KALA
$14.6M
| $28.7K | ﹤0.01% |
+1
| New | +$46.8K |
|
|
VIVS
3850
VivoSim Labs
VIVS
$1.27M
| $28.7K | ﹤0.01% |
89
+52
| +141% | +$19.3K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2017 Portfolio in Review
As of Q4 2017, BNP Paribas Financial Markets held 4,431 positions worth $56.4B, up 38% from $40.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $12.4B of net new capital in Q4 2017, opening 182 new positions and adding to 2,292 existing holdings. Its largest new stake was VanEck Junior Gold Miners ETF: 1,804,222 shares worth $61.6M.
By sector, the portfolio is most concentrated in Communication Services at 4.9% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Citigroup, an estimated $1.43B trimmed.
- BNP Paribas Financial Markets's largest Q4 2017 buy was VanEck Junior Gold Miners ETF: 1,804,222 shares worth $61.6M.
- BNP Paribas Financial Markets added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $78.3M increase.
- BNP Paribas Financial Markets's biggest Q4 2017 reduction was Citigroup, cutting an estimated $1.43B.
- BNP Paribas Financial Markets fully exited CR Bard Inc. in Q4 2017, selling an estimated $113M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $56.4B portfolio in Q4 2017.
- BNP Paribas Financial Markets opened 182 new positions and closed 204 in Q4 2017.
- BNP Paribas Financial Markets's portfolio value rose 38% quarter-over-quarter to $56.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2017, filed 1 Feb 2018.